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1 Introduction
In clinical trials, patients normally arrive sequentially. Response-adaptive treatment alloca-
tion procedures are sequentially adaptive schemes that uses past treatment assignments and
patients’ responses to select future treatment assignments. Historically, response-adaptive
treatment allocation procedures were developed for the purpose of assigning more patients
to the empirically better treatment. Early important work on response-adaptive designs
can be traced back to Thompson (1933) and Robbins (1952). Since then, a lot of response-
adaptive designs have been proposed in literature. A history of the subject is discussed in
Rosenberger and Lachin (2002) and Hu and Rosenberger (2006). The most famous non-
randomized response-adaptive treatment allocation procedure is the play-the-winner (PW)
rule proposed by Zelen (1969), in which a success on a treatment results in the next patient’s
assignment to the same treatment, and a failure on the treatment results in the next pa-
tient’s assignment to the opposite treatment. The idea of incorporating randomization into
response-adaptive treatment assignments is due to Wei and Durham (1978), who proposed
a randomized play-the-winner (RPW) rule for binary outcome trials. With this approach,
each patient’s treatment assignment is determined by drawing a ball from an urn, and the
urn composition is updated by adding an additional ball of the same type if the patient’s
response is a success and an additional ball of the opposite type if the patient’s response
is a failure, so that the ball corresponding to the better treatment has a larger probabil-
ity to be drawn. The RPW rule was used to design a pediatric trial of extracorporeal
membrane oxygenation (ECMO; Bartlett et al., 1985), which compared the ECMO therapy
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versus the conventional therapy. Unfortunately, the trial provided very little information
about survival rates of the two treatments. The trial stopped after enrolling 12 infants,
of whom one infant was randomized to the conventional therapy and died and 11 infants
were randomized to ECMO treatment and all survived. This design and subsequent data
analysis generated a lot of controversy and much of the criticism of response-adaptive ran-
domization (RAR) designs; in fact the ECMO trial example is still often used as a reason
not to perform response-adaptive randomization at all. According to the modern theory on
response-adaptive randomization designs, the failure of the ECMO trial can be explained
mainly by the trial’s small sample size and the poor operating characteristics of the RPW
rule, in particular, the rule’s high variability and dependence on the initial composition of
the balls in the urn. Since the time of the ECMO trial, the body of knowledge on response-
adaptive randomization has grown significantly and many new methods have been proposed
to address past criticisms and concerns that have hindered the use of adaptive randomiza-
tion in clinical trials. In this paper we provide an overview of important research works
on response-adaptive randomization completed in the past decades. In the next section,
we give the general framework. The RPW rule is only one example of a broad class of
randomized urn models and is generalized to the “generalized Po´lya urn model” (GPU).
Other notable response-adaptive randomization urn designs with desirable statistical prop-
erties are proposed in the past decades including the “drop-the-loser (DL) rule” by Ivanova
(2003), “sequential estimated-adjusted urn” (SEU) by Zhang, Hu and Cheung (2006), the
“generalized drop-the-loser (GDL) rule” by Zhang et al. (2007), and the “immigrated urn
(IMU) model” by Zhang et al. (2011). We state the theory on urn models in Section 3.
Modern research on response-adaptive randomization has focused on the development of
optimal response-adaptive randomization procedures that maintain or increase power over
traditional balanced randomization designs and minimize expected treatment failures. The
optimization problem and the efficiency of the response-adaptive randomization designs are
discussed in Section 4, where the methods and theoretical principles are proposed for defining
a design with desirable or most desirable statistical properties. The asymptotic properties
of several modern designs such as “doubly adaptive biased coin design” (DBCD) of Hu and
Zhang (2004a), “efficient response adaptive randomization designs”(ERADE) of Hu, Zhang
and He (2009) etc are presented. In section 5, the selection bias and the lack of randomness
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are discussed. The measures for evaluating the selection bias and the degree of the lack
of randomness are defined and the measure values of several randomization procedures are
given. Survival and delayed responses are briefly discuss in Section 6. A theorem is given
for showing that the mild delay will not effect the theoretical results of response-adaptive
randomization designs. The last section gives a concluding remark.
2 Framework
We consider K-treatment clinical trials, K ≥ 2. Suppose that the outcome of treatment k
follows a probability distribution fk(x|θk) indexed by a parameter θk. The patients arrive
at the clinical trial sequentially and will be allocated to one of the K treatments with a
certain probability one by one. After the first m assignments, the (m + 1)-th patient will
be assigned to treatment k with a probability
pm+1,k, k = 1, . . . ,K.
The probabilities pm+1,ks are usually functions of the allocation results and outcomes of the
treatments of previous m trials. Let Nm,k be the number of the patients assigned to the
treatment k in the firstm stages, k = 1, . . . ,K, andNm = (Nm,1, . . . , Nm,K). Two problems
are always concerned in the adaptive randomization studies. One is the way for defining
the allocation probabilities pm+1,ks so that the design will achieve the desired purposes in
clinical trials. The other is the theory on the behaviors of Nm,ks and related statistical
inference.
When K = 2, in the play-the-winner rule of Zelen (1969), the allocation probability
pm+1,k is defined to be 1 if the m-th patient is assigned to treatment k and success, and 0
otherwise, k = 1, 2. And in the randomized play-the-winner rule of Wei and Durham (1978),
the allocation probability pm+1,k is defined to be the current proportion of balls of type k
in the urn:
pm+1,k =
Ym,k
Ym,1 + Ym,2
,
where Ym,k is the number of balls of type k and is defined successively by Ym,k = Ym−1,k+1
if the (m−1)-th patient is assigned to treatment k and successes, or the (m−1)-th patient is
assigned to the other treatment and fails. For both the play-the-winner rule and randomized
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play-the-winner rule, it is shown that
Nn,k
n
→ qk
q1 + q2
in probability,
where qk is the failure rate of the treatment k, k = 1, 2.
3 Urn Models
In the latter part of the 20th century, most research on response-adaptive randomization
focused on ad hoc designs based on stochastic processes such as urn models (see Rosenberger,
2002). Many of these were extensions of the randomized play-the-winner methodology, and
they focused on putting more patients on the superior treatment. One large family is the
family of the generalized Po´lya urn models.
3.1 Generalized Po´lya Urn
Consider an urn containing balls of K types. At the beginning, the urn contains Y0 =
(Y0,1, . . . , Y0,K) particles, where Y0,k > 0 denotes the number of particles of type k, k =
1, . . . ,K. After m assignments, the urn composition is denoted by the row vector Ym =
(Ym,1, . . . , Ym,K). The (m + 1)-th patient is randomized to treatments by drawing a ball
from the urn with replacement. If the ball drawn is of type k, then the patient is assigned
to treatment k, i.e., the allocation probability is defined as
pm+1,k =
Ym,k
|Ym| , k = 1, . . . ,K,
where |Ym| = Ym,1+ · · ·+Ym,K. We then wait for observing a random variable ξ(m+1), the
response of the treatment k at the (m+1)-th patient. After that, additional Dk,q(m+1) ≥ 0
balls of type q, q = 1, . . . ,K, are added to the urn, where Dk,q(m + 1) is a function of
ξ(m + 1) and also may be a function of urn compositions, assignments and responses of
previous stages. This procedure is repeated through out n stages. This relation can be
written as the following recursive formula:
Ym = Ym−1 +XmDm, (3.1)
where Dm =
(
Dk,q(m)
)K
k,q=1
, and Xm is the result of the m-th draw, distributed according
to the urn composition at the previous stage, i.e., if the mth draw is a type k ball, then the
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kth component of Xm is 1 and other components are 0. The matrices Dm’s are referred to
as the adding rules. The conditional expectationsHm =
(
E[Dk,q(m)
∣∣Fm−1])dk,q=1, given the
history sigma field Fm−1 generated by the urn compositions Y1, . . . ,Ym−1, the assignments
X1, . . . ,Xm−1 and the responses ξ(1), . . . , ξ(m − 1) of all previous stages, m = 1, 2, . . .,
are referred to as the generating matrices. When Dm, m = 1, 2, . . . , are independent
and identically distributed, the GFU model is usually said to be homogeneous. In such case
Hm =H are identical and nonrandom, and usually the adding ruleDm is merely a function
of the mth patient’s observed outcome. In the general heterogeneous cases, both Dm and
Hm depend on the entire history of all previous trials which provides more information of
the efficacy of the treatments. However, we should suppose that Hm will converge to a
matrix H.
The randomized play-the-winner rule is a homogeneous urn model with
Dm =
 ξm,1 1− ξm,1
1− ξm,2 ξm,2
 , H =
p1 q1
q2 p2
 ,
where ξm,k = 1 if the response of the m-th patient on treatment k is a success, and = 0 for
otherwise, pk is the success probability of treatment k, qk = 1− pk, k = 1, 2.
For considering the asymptotic properties ofNn, we suppose thatH has a simple largest
eigenvalue β > 0 and the corresponding right eigenvector v = (v1, . . . , vK) and the left
eigenvector u′ = (u1, . . . , uK)′ with
∑
k vk =
∑
k vkuk = 1 and vk > 0, uk > 0, k = 1, . . . ,K.
Define ∆Mm,1 = Xm − E[Xm|Fm−1], ∆Mm,2 = Xm(Dm −Hm) and H = H − β1′v,
where 1 = (1, . . . , 1). It can be shown that |Ym| ∼ βm and
∆Ym =Ym − Ym−1 (3.2)
=Xm(Dm −Hm) + (Xm − E[Xm|Fm−1])Hm + Ym−1|Ym−1|Hm
=v +∆Mm,1(Hm − β1′v) + ∆Mm,2 +
(
Ym−1
|Ym−1| − v
)(
H − β1′v)
+
(
Ym−1
|Ym−1| − v
)(
Hm −H) + v(Hm −H)
≈βv +∆Mm,1(Hm − β1′v) + ∆Mm,2 +
(
Ym−1
β(m− 1) − v
)
H + v(Hm −H)
If we ignore the remainder v(Hm−H) and replace the martingales Mn,1 andMn,2 by two
(independent) Brownian motions B1(n)Σ
1/2
1 and B2(n)Σ
1/2
2 , we conclude that
Yn − βnv ≈ G1(n)H +G2(n) (3.3)
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with Gj(t) satisfying the stochastic differential equation (SDE):
dGj(t) = dBj(t)Σ
1/2
j +
Gj(t)
t
H
β
dt, Gj(0) = 0 or Gj(1) = 0, (3.4)
where B1 and B2 are two independent standard Brownian motions, Σ1 = diag(v) − v′v
and Σ2 = lim
m→∞
(∑K
k=1 vkVar{D(k)m |Fm−1}
)
and D
(k)
m is the k row of Dm. Further,
∆(Nt − tv) = ∆Mt,1 + Yt−1|Yt−1| − v
≈dB1(t)Σ1/21 +
G1(t)H +G2(t)
βt
dt = dG1(t) +
G2(t)
βt
dt,
So,
Nn − nv ≈ G1(n) +
∫ n
∗
G2(t)
βt
dt. (3.5)
By calculating the variance of the Gaussian processes G1(t) and G2(t), one can derive the
asymptotic normality of Yn and Nn.
For details on the asymptotic normalities of urn models, one can refer to Bai, Hu and
Rosneberger (2002), Hu and Zhang (2004b), Bai and Hu (2005), Zhang and Hu (2009),
Zhang (2012) etc. Among these studies, Bai, Hu and Zhang (2002), Hu and Zhang (2004b),
Zhang and Hu (2009), Zhang (2012) studied the asymptotic properties via the Gaussian
approximation. The following Theorem 3.1 and Corollary 3.1 give a summary of theses
results.
Theorem 3.1 Suppose supm E‖Dm‖2+δ < ∞. Let λ1 = β, λ2, . . . , λK be the eigenvalues
of H, and λ = max{Re(λ2)/λ1, . . . , Re(λK)/λ1}.
(i) If λ < 1 and
∑n
m=1 ‖Hm −H‖ = o(n) a.s., then
Nn,k
n
→ βvk a.s. and
Yn,k
Yn,1 + · · ·Yn,K → vk a.s.
(ii) If λ < 1/2 and
n∑
m=1
‖Hm −H‖ = o(
√
n) a.s., (3.6)
then
√
n
(Yn
n
− βv
) D→ N(0,Γ1) and √n(Nn
n
− v
) D→ N(0,Γ2).
(iii) If λ = 1/2 and
∑n
m=1 ‖Hm −H‖/
√
m = o(
√
log n) a.s., then
√
n
(log n)ν−1/2
(Yn
n
− βv
) D→ N(0,Γ∗1) and √n(log n)ν−1/2(Nnn − v) D→ N(0,Γ∗2).
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(iv) If 1/2 < λ < 1 and
∑n
m=1 ‖Hm −H‖ = o(nλ−ǫ) a.s., then
‖Yn − βnv‖ = O(nλ logν−1 n) a.s. and ‖Nn − nv‖ = O(nλ logν−1 n) a.s.
Here ν is the largest order of the Jordan blocks with respect to the eigenvalues λs with
Re(λs)/λ1 = λ.
For the randomized play-the-winner rule, we have β = 1, λ = p1 + p2 − 1. The problem
is reduced to the one-dimensional problem: Yn,1 − nv1 ≈ G1(n)λ + G2(n), Nn,1 − nv1 ≈
G1(n) +
∫ n
∗
G2(t)
t dt,
dGj(t) = σjdBj(t) + λ
Gj(t)
t
dt
with σ21 = v1v2 =
q1q2
(q1+q2)2
and σ22 = v1p1q1 + v2p2q2 =
q1q2(p1+p2)
q1+q2
.
Corollary 3.1 (a) If p1+p2 < 1.5, then
√
n
(
Nn,1/n− q2/(q1+ q2)
) D→ N(0, σ2RPW ), where
σ2RPW =
q1q2[5− 2(q1 + q2)]
[2(q1 + q2)− 1](q1 + q2)2 , and
√
n
( Yn,1
Yn,1 + Yn,2
− q2
q1 + q2
) D→ N(0, q1q2
(2(q1 + q2)− 1)(q1 + q2)2
)
.
(b) If p1 + p2 = 1.5 , then
√
n/ log n
(
Yn,1/n− q2/(q1 + q2)
) D→ N(0, 4q1q2), and
√
n/ log n
(
Nn,1/n− q2/(q1 + q2)
) D→ N(0, 16q1q2).
(c) If p1 + p2 > 1.5, then there exists a random variable ξ such that
np1+p2−1
(
Yn,1 − nq2/(q1 + q2)
)→ ξ/2 a.s., and
np1+p2−1
(
Nn,1 − nq2/(q1 + q2)
)→ ξ a.s.
As a multi-treatment extension of the RPW rule, Wei (1979) proposed a GPU model
to allocate patients, in which the urn is updated in the following way: at the mth stage,
if a patient is assigned to treatment k and the outcome is a success, then a type k ball is
added to the urn, otherwise, if the treatment k for a patient is a failure, then 1/(K − 1)
balls are added to the urn for each of other (K − 1) types. This urn model is a homogenous
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urn model with H = {hk,j}, where hk,k = pk and hk,j = qk/(K − 1) (j 6= k), and qk is the
failure rate of treatment k, pk = 1− pk is the success probability. So, vk = 1/qk∑K
j=1(1/qj)
.
One important class of the non-homogenous urn model is the sequential estimation-
adjusted urn model proposed by Zhang, Hu and Cheung (2006), in which the urn is updated
according to the current response and the current estimate θ̂m of the parameter θ, and so
H(θ̂m) is a function of the current estimator. In this case, the fastest convergence rate of
Hm −H is OP (
√
m) so that the condition (3.6) is not satisfied and the term v(Hm −H)
can not be ignored. In this case,
v(Hm −H) ≈
(
θ̂m − θ
)∂[vH(θ)]
∂θ
≈ W3(m)
m
∂[vH(θ)]
∂θ
,
where W3(t) is another Brownian motion which is independent of B1(·), but may depend
on B2(·). The variance-covariance of
(
B1(t)Σ
1/2
1 ,B2(t)Σ
1/2
2 ,W3(t)
)
is given in (5.23) of
Zhang, Hu and Cheung (2006).
Hereafter, for a vector function g(x), its derivative ∂g(x)∂x =
(
∂gk(x)
∂xj
; j, k = 1, . . . ,K
)
is a
matrix. In the approximation (3.3) and (3.5), G2(t) should be replaced with G2(t) +G3(t)
and
dG3(t) =
W3(t)
t
dt+
G3(t)
t
H
β
dt.
The conclusions of Theorem 3.1 remains true with a different group of variance-covariance
matrices.
In particular, suppose θ̂m = (θ̂m,1, . . . , θ̂m,K) is the maximum likelihood estimator of
the parameter θ = (θ1, . . . ,θK) based on the responses available up to stage m. If we define
Dm =Hm = β1
′ρ
(
θ̂m
)
with ρk(·) > 0 and
∑
k
ρk(·) = 1, β > 0,
then Nn − nv = O(
√
n log log n) a.s. and
√
n
(Nn
n
− ρ
) D→ N(0, diag(ρ) − ρ′ρ+ 6ΣLB), (3.7)
where ρ = ρ(θ),
ΣLB =
(∂ρ(θ)
∂θ
)′
daig
(I−11 (θ1)
ρ1(θ)
, · · · , I
−1
K (θK)
ρK(θ)
)∂ρ(θ)
∂θ
, (3.8)
and Ik(θk) is the Fisher information for a single observation on treatment k = 1, . . . ,K.
Hereafter, I−1k denotes the inverse matrix of Ik.
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When the estimator θ̂m of the parameter θ is utilized to update the allocation probabil-
ities, the adaptive randomization scheme can start only after an initial estimator is defined
because at the first few steps there are insufficient data for estimating θ. In general, there
are three ways to overcome this problem: 1) initial Km0 patients (m0 is some small positive
integer) are randomized to treatments 1, . . . ,K by means of some restricted randomization
design, and their outcomes are used to estimate θ; 2) choose an initial value θ0 as the es-
timator until sufficient amount of data are collected to estimate θ (the value θ0 is usually
a guess value of the parameter or an estimate from other trials); 3) apply the Bayesian
estimation method.
3.2 Drop-the-Loser
The asymptotic normality for the randomized play-the-winner rule as well as its extensions
to generalized Po´lya urn models can be obtained only when the condition ρ ≤ 1/2 is satisfied,
and the variabilities are very large. Many of these designs are slow to converge and produce
less powerful treatment comparison hypothesis tests. In the family of urn models, a major
advance was made by Ivanova (2003), who introduced ”the drop-the-loser rule”, an urn
model design with the same limiting allocation as the RPW rule but with much lower
variability. In the drop-the-loser rule, an urn is considered with balls of (K +1) types, type
0, 1, . . . ,K, when comparing K treatments. Types 1, . . . ,K are called treatment types, and
type 0 is called the immigration type. When a patient is ready for randomization, a ball is
drawn at random. If it is of a treatment type, the corresponding treatment is assigned and
the patient’s response is observed. If the response is a success, the ball is replaced and the
urn remained unchanged. If a failure the ball is not replaced. When an immigration type
ball is drawn, no treatment assignment is made, and the ball is return to the urn together
with one ball of each treatment type. Ivanova (2003,2006) showed the asymptotic normality
by embedding the urn process to a death-and-immigration process.
Theorem 3.2 Let v = (v1, · · · , vK) with vk = 1/qk∑K
j=1(1/qj)
. Then
√
n
(Nn
n
− v
)
D→ N(0,ΣDL)
with ΣDL = (I − v′1)diag
(
v1p1
q1
, · · · , vKpKqK
)
(I − 1′v). It can be verified that
ΣDL =
(∂v
∂q
)′
diag
(p1q1
v1
, · · · , pKqK
vK
)∂v
∂q
.
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In particular, for the two-treatment case,
√
n
(Nn,1
n
− q2
q1 + q2
)
D→ N
(
0,
q1q2(p1 + p2)
(q1 + q2)3
)
.
The asymptotic normality of DL rule holds for all cases of 0 < p1, p2 < 1 and the variability
q1q2(p1+p2)
(q1+q2)3
is much smaller than the one of the RPW rule. For the multi-treatment case, the
formula of ΣLD in Ivanova (2006) is given in a different expression. The present one is due
to Zhang et al. (2011).
3.3 Generalized Drop-the-Loser and Immigrated Urn Model
Generalizations of the drop-the-loser rule can be found in Zhang et al. (2007), Sun, Cheung
and Zhang (2007) and Zhang et al. (2011). Zhang et al. (2011) proposed an immigrated urn
model which provides a unified theory of urn models for clinical trials. In an immigrated
urn model, as in the drop-the-loser rule, the urn contains balls of (K + 1) types, where
types 1, . . . ,K stand for treatment types, and type 0 stands for the immigration type. After
m assignments, suppose the urn composition is (Ym,0, Ym,1, . . . , Ym,K). For the (m + 1)-th
patient’s treatment assignment, a ball is drawn at random. If an immigration type ball is
drawn, no assignment is made, and the ball is return to the urn together with am+1,k ≥ 0
balls of type k, k = 1, . . . ,K. The process is repeated until a ball of a treatment type
is drawn. If the ball drawn is of type k (k = 1, . . . ,K), the corresponding treatment is
assigned and the patient’s response ξ(m + 1) is observed. The ball is also return with
additional Dk,j(m + 1) balls of each treatment type j, j = 1, . . . ,K. Dk,j(m + 1) is a
function of the response ξ(m + 1) =
(
ξ1(m + 1), . . . , ξK(m + 1)
)
. In the IMU model, the
diagonal elements of Dm+1 allow negative values, which means the dropping of balls, and
am+1,k = ak(θ̂m) can be a function of the current estimator θ̂m of the parameter θ. The
vector am = (am,1, . . . , am,K) are called the immigration rates. When am,k ≡ 0 and Y0,0 = 0,
the IMU reduces to GPU. When Dm is diagonal and its elements have negative means, the
IMU is the generalized drop-the-loser rule proposed by Zhang et al. (2007) and Sun, Cheung
and Zhang (2007). Here when the urn allows balls with negative numbers, we assume that
the balls of a type with a negative number have no-chance to be selected and so the selection
probabilities are the proportions of positive numbers of balls in the urn.
For considering the theory of the IMU model, without loss of generality, we suppose the
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parameter θk is one-dimensional and the mean of the response ξk(m) and the estimator θ̂m,k
is the current sample mean, and assume that {(Dm, ξ(m))} are i.i.d. Let H = E[Dm] be
the mean matrix as in the GPU model. If H1′ = β1′ with β > 0, i.e., at each stage the
average of the total number of balls added according the treatments are positive, then the
total number of balls in the urn gradually increases to infinity. Hence, the probability of
drawing an immigration ball drops to zero. For this case, the IMU model is asymptotically
equivalent to the generalized Po´lya urn model without immigration, and the conclusions of
Theorem 3.1 remain true. When H1′ < 0′, the urn composition is mainly updated by the
immigration, and we have the following theorem.
Theorem 3.3 Let A = (−H)−1(I − 1′v),
v(θ) = (v1, . . . , vK) =
a(θ)(−H)−1
a(θ)(−H)−11′ ,
Σ11 =
∑K
k=1 vkVar{D(k)1 }, ΣD = A′Σ11A,
Σ12 = (Cov{D1,kj , ξk}; j, k = 1, . . . ,K), ΣDξ = A′Σ12 ∂v(θ)∂θ ,
Σξ =
(
∂v(θ)
∂θ
)′
diag
(
Var{ξ1,1}
v1
, . . . ,
Var{ξ1,K}
vK
)
∂v(θ)
∂θ ,
and Σ = ΣD + 2Σξ + ΣDξ + Σ
′
Dξ. Suppose E‖Dm‖2+ǫ < ∞, E‖ξ(m)‖2+ǫ < ∞, and
H1′ < 0′, Y0,0 > 0. Then
Yn,k = o(n
1/2−ǫ) a.s., k = 1, . . . ,K, Nn − nv = O(
√
n log log n) a.s.
and
√
n
(Nn
n
− v(θ)
)
D→ N(0,Σ).
In particular,
(i) when Dm ≡ const (for example Dm = diag(−1, . . . ,−1)), one has
√
n
(Nn
n
− v(θ)
)
D→ N(0, 2Σξ); (3.9)
(ii) when a(θ) ≡ const and each Dm,kj is a linear function of ξm,k, j = 1, . . . ,K, so that
v is a function of θk = Eξm,k,k = 1, . . . , k, one has
√
n
(Nn
n
− v(θ)
)
D→ N(0,Σξ).
When H1′ = 0, we have Nn − nv = O(
√
n log log n) a.s. and Nn − nv = O(
√
n) in
probability. The asymptotic normality is still an open problem.
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3.4 Randomly Reinforced Urn
Another type of urn models, called randomly reinforced urn (RRU), are also proposed for
randomizing patients to treatments. In a response-adaptive design driven by a RRU model,
an observation of an outcome from treatment k results in only adding balls of the same type
k. A RRU procedure leads to an extreme limiting allocation so that the sample allocation
proportions of the best treatment converges to 1, and others converge to zero. For the
properties of the RRU design, one may refer to Li, Durham and Flournoy (1996), May
and Flournoy (2009), Zhang et al. (2014a) etc. However, the RRU design has very high
variability and so is not strongly recommended in the term of power.
4 Optimal and Efficient RAR Designs
The RPW rule and many of its extensions based on urn models were proposed by the
intuitive motivation of placing more patients on the superior treatment, and they were not
designed to optimize any criterion. Hu and Rosenberger (2003) formalized the development
of optimal response-adaptive randomization procedures using the following three steps:
1) An optimal allocation is derived as a solution to some formal optimization problem.
2) A response-adaptive randomization procedure is chosen to converge to the optimal target.
The procedure should be fully randomized, have minimal variability, and high speed
of convergence to the chosen optimal allocation.
3) Operating characteristics of the chosen response-adaptive randomization design are stud-
ied theoretically and by simulation under a variety of standard to worst-case scenarios.
4.1 Optimization
For two-treatment trials, a general optimization problem is described in Jennison and Turn-
bull (2000), which led to the development of optimal response-adaptive randomization de-
signs for trials with binary responses (Rosenberger et al. (2001); Ivanova and Rosenberger
(2001); Rosenberger and Hu (2004); Baldi Antognini and Giovagnoli (2010)), normal out-
comes (Biswas and Mandal (2004); Zhang and Rosenberger (2006); Gwise, Hu and Hu
(2008); Biswas and Bhattacharya (2009, 2010, 2011)), and survival outcomes (Zhang and
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Rosenberger (2007)). The most interesting optimal allocation targets are the Neyman allo-
cation for continuous response and the RSIHR allocation for binary responses.
In Jennison and Turnbull (2000)’s approach, let ξm,1 arise from a N(µ1, σ
2
1) distribution
and ξm,2 arise from a N(µ2, σ
2
2) distribution, m = 1, 2, . . .. For testing the treatment effect
θ =: µ1 − µ2 = 0, a natural test is the Wald test given by
Z =
µ̂1 − µ̂2√
σ̂2
1
n1
+
σ̂2
2
n2
,
where n1 and n2 are the sample size for treatment 1 and 2. The (asymptotic) power of the
test is a decreasing of
η(θ) =
σ21
n1
+
σ22
n2
.
Fixing η to a constant, say δ, we wish to find the value of n1n1+n2 that minimizes
u(θ)n1 + v(θ)n2,
where u(·) and v(·) are appropriately chosen functions of θ. Because we wish to put more
patients on treatment 1 if θ > 0 and more patients on treatment 2 if θ < 0, Jennison and
Turnbull explore functions where u(·) and v(·) are strictly positive, and u(θ) is decreasing in
θ for θ < 0 and v(θ) is increasing in θ for θ > 0. By using the Lagrange multiplier method
and minimizing
u(θ)n1 + v(θ)n2 + λ
(σ21
n1
+
σ22
n2
−K
)
,
a minimum is achieved at
n1
n1 + n2
= ρ1 =:
σ1/
√
u(θ)
σ1/
√
u(θ) + σ2/
√
v(θ)
.
If u(·) ≡ v(·) ≡ 1, then we have ρ1 = σ1/(σ1 + σ2), which is the Neyman allocation. This
allocation maximizes the power of the usual Z-test for fixed sample size n1 + n2 = n.
In the case of the binary responses, for testing the equality of treatment effects, the Wald
test is given by
Z =
p̂1 − p̂2√
p̂1q̂1
n1
+ p̂2q̂2n2
,
where p̂k is the estimator of the cured rate pk, and q̂k = 1− p̂k, k = 1, 2. Rosenberger et al.
(2001) suggested fixing the asymptotic variance η(q1, q2) =
p1q1
n1
+ p2q2n2 to a constant, say δ,
and minimizing the average failure number q1n1 + q2n2. The minimum is achieved at
n1
n1 + n2
= ρ1 =:
√
p1√
p1 +
√
p2
.
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We refer to this as RSIHR allocation.
Many other optimal allocations can be found in literature. For example, Zhang and
Rosenberger (2006) proposed the following allocation for normal responses with positive
means by minimizing the mean total response for fixed power:
ρ1(θ) =
√
µ2σ1√
µ2σ1 +
√
µ1σ2
;
By minimizing the total number of patients with normal response greater than a constant
given c, Biswas and Mandal (2004) obtained an allocation as
ρ1(θ) =
√
Φ
(
u2−c
σ2
)
σ1√
Φ
(
u2−c
σ2
)
σ1 +
√
Φ
(
u1−c
σ1
)
σ1
.
For multi-arm clinical trials, Tymofyeyev, Rosenberger and Hu (2007) introduced a
general approach for finding allocations to minimize a weighted sum of treatment sample
sizes subject to minimal constraints on the power of a homogeneity test and treatment
proportions in the trial. Let φ(n1, . . . , nK) be the noncentrality parameter of a suitable
multivariate test statistics of interest under the alterative hypothesis, where nk is sample
size for treatment k, n1 + · · · nK = n. We assume that the noncerntrality parameter is
a concave function with nonnegative gradient. Tymofyeyev, Rosenberger and Hu (2007)
suggested considering a general optimization problem:
min
n1,...,nK
K∑
j=1
wjnj,
such that
nk∑K
j=1 nj
≥ B, k = 1, . . . ,K,
φ(n1, . . . , nK) ≥ C,
or equivenlently,
max
m1,...,mK
φ(m1, . . . ,mK)
such that
mk∑K
j=1mj
≥ B, k = 1, . . . ,K,
K∑
j=1
wjmj ≤M,
to derive the allocation target ρk = nk/
∑K
j=1 nj = mk/
∑K
j=1mj . Here wj are positive
weights, and the nonnegative constant B with KB ≤ 1 is a lower bound for the proportion
14
nk/
∑K
j=1 nj (resp. mk/
∑K
j=1mj) that allows us to control explicitly the feasible region
of the problem. Under this framework, Jeon and Hu (2010), for binary trials with K = 3
treatments, obtained the analytic solution for an allocation minimizing expected treatment
failures in the trial subject to minimal constraints on power and treatment proportions. Sim-
ilar results were obtained by Zhu and Hu (2009) for exponential outcomes and by Sverdlov,
Tymofyeyev and Wong (2011) for censored exponential outcomes.
Also, there is a lot papers considering the D-optimization, DA-optimization etc. In
general, let M(ρ,θ) denote the Fisher information matrix for θ given a design allocation
ρ = (ρ1, . . . , ρK). By minimizingM
−1(ρ,θ) in some sense (by choice of ρ) one can achieve
most accurate inference for the parameters of interest. For normal response trials with
heteroscedastic outcomes, Wong and Zhu (2008) and Gwise, Zhu and Hu (2011) obtained
DA-optimal designs that maximize efficiency for estimating treatment contrasts. Sverdlov
and Rosenberger (2013a) give a comprehensive overview of various single- and multiple-
objective optimal allocation designs that are available in the literature.
4.2 Target Driven Randomization
In general, the optimal allocation proportion vector ρ = (ρ1, . . . , ρK) derived as a solution
to some optimization problem is a function of the distribution parameters θ = (θ1, . . . ,θK).
In practice, one can construct a response-adaptive randomization design such that the sam-
ple allocation proportions sequentially converge to the chosen optimal allocation ρ(θ) =(
ρ1(θ), . . . , ρK(θ)
)
. We shall assume that the target function ρ(θ) is a continuous func-
tion on the parameter space and twice differentiable at the true value of the parameter
θ = (θ1, . . . ,θK). In general, one can use a smoothing mothod to modify the target func-
tion (c.f. Tymofyeyev, Rosenberger and Hu (2007)).
In the two-treatment trails with binary responses, the sample allocations Nn,1/n and
Nn,2/n in both the RPW rule and DL rule sequentially converge to allocation proportion
ρ1 = q2/(q1 + q2) and ρ2 = 1− ρ1. However, the RPW and the DL rule can only target this
specified allocation.
In general, given an allocation proportion vecotr ρ(θ), if we apply the SEU model with
adding rules Dm = β1
′ρ
(
θ̂m
)
(β > 0), then we will have Nn/n → ρ(θ) a.s. and the
asymptotic normality given by (3.7). Here we always assume that θ̂m is the MLE of θ, or
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simply the sample means of the responses, based on the data from the previousm trials. In a
SEU model with adding rules Dm = β1
′ρ
(
θ̂m
)
, when the (m+1)-th patient is randomized,
no matter what its response is, the urn is updated by adding additional βρj(θ̂m) balls of
type j, j = 1, . . . ,K. The outcomes of treatments are only used to get the estimator θ̂m.
Also, if we apply the IMU model with immigration rates a(θ̂m) = βρ(θ̂m) (β > 0) and
adding rules Dm = diag(−1, · · · ,−1), then we will also have Nn/n → ρ(θ) a.s. and the
asymptotic normality given by (3.9). This procedure is the generalized drop-the-loser rule
proposed by Zhang et al. (2007) and Sun, Cheung and Zhang (2007). In the GDL rule,
when a treatment ball is drawn, it is always dropped. When an immigration ball is drawn,
the ball is returned with additional βρj(θ̂m) balls of type j, j = 1, . . . ,K. The outcomes
of treatments are only used to estimate the parameter θ and get the current estimated
immigration rates ρ(θ̂m).
Another simple approach to construct a response-adaptive randomization design such
that Nn/n→ ρ(θ) is defining the allocation probabilities of the (m+ 1)-th patient by
pm+1,k = ρ̂m,k, k = 1, . . . ,K,
where ρ̂m =
(
ρ̂m,1, . . . , ρ̂m,K
)
with ρ̂m,k = ρk
(
θ̂m
)
denotes the estimated target allocation.
This is the sequential maximum likelihood procedure (SMLP) proposed by Melfi and Page
(2000) and Melfi, Page, and Geraldes (2001).
A general allocation rule is defining the allocation probabilities as a function of both
current sample allocation proportions and the estimated target allocation:
pm+1,k = gk (Nm/m, ρ̂m) , k = 1, . . . ,K,
where g(x,y) =
(
g1(x,y), . . . , gK(x,y)
)
(gk(x,y) ≥ 0 and
∑K
k=1 gk(x,y) = 1) is called
the allocation function. This is the doubly adaptive biased coin design proposed by Hu and
Zhang (2004a), extending the work of Eisele (1994).
For a general function g, the convergence of Nn/n is related to the stability of the
following ordinary differential equation:
x˙ = x− g(x,ρ(θ)), with x = x(s),
where x˙(s) is the derivative of x(s) (c.f. Zhang (2014)). If the function g is chosen such
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that gk(x,y) ≤ λ(xk − yk) whenever xk > yk, where 0 ≤ λ < 1, then
Nn
n
→ ρ(θ) a.s.
This is proved by Hu and Zhang (2004a) and Hu et al. (2008), and they proposed the
following allocation function:
gk(x,y) =
yk
( yk
xk
)γ∑K
j=1 yj
( yj
xj
)γ , k = 1, . . . ,K, (4.1)
where γ ≥ 0 is user-defined parameter controlling the degree of randomness (γ = 0 is almost
completely randomized and γ = ∞ is almost deterministic procedure). The SMLP is a
special case of DBCD with γ = 0.
For considering the asymptotic normality, we note that
θ̂m,k − θk ≈
∑m
j=1Xj,kηm,k
Nm,k
≈ Bk(m)I
−1/2
k
√
ρk
mρk
=
Bk(m)I
−1/2
k
m
√
ρk
,
Mn =
m∑
j=1
(Xj − E[Xj |Fj−1]) ≈ B(t)Σ1/21 ,
where ηm,k is a function of the response ξ(m) with Eηm,k = 0 and Var(ηm,k) = I
−1
k
with Ik = Ik(θk) being the Fisher information for a single observation on treatment
k = 1, . . . ,K, B(t),B1(t), . . . ,BK(t) are independent multi-dimensional standard Browian
motions, Σ1 = diag(ρ) − ρ′ρ. Hereafter, for a symmetric and positive definite matrix
Σ, Σ1/2 is the symmetric matrix such that Σ1/2Σ1/2 = Σ, and Σ−1/2 is the inverse
matrix of Σ1/2 satisfying Σ−1/2Σ−1/2 = Σ−1. Write W (t) =
(
B1(t), . . . ,BK(t)
)
and
I(θ) = daig
(
ρ1(θ)I1, . . . , ρk(θ)IK
)
. Then
θ̂m − θ ≈W (m)I
−1/2(θ)
m
,
∆(Nm −mv) ≈∆Mm,1 +
(Nm−1
m− 1 − v
)∂g(ρ,ρ)
∂x
+
(
θ̂m−1 − θ
)∂ρ(θ)
∂θ
∂g(ρ,ρ)
∂x
.
So
Nn − nv ≈ G(n) with G satisfying the SDE:
dG(t) = dB(t)Σ
1/2
1 −
G(t)
t
∂g(ρ,ρ)
∂x
dt+
W (t)
t
I−1/2(θ)
∂ρ(θ)
∂θ
∂g(ρ,ρ)
∂x
dt.
Suppose the allocation function is chosen as in (4.1), then ∂g(ρ,ρ)∂x = −γ(I − 1′ρ) and
∂g(ρ,ρ)
∂y = (γ + 1)(I − 1′ρ). The SDE can be simplified to
dG(t) = dB(t)Σ
1/2
1 − γ
G(t)
t
dt+ (γ + 1)
W (t)
t
I−1/2(θ)
∂ρ(θ)
∂θ
dt,
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which has a solution
G(t) = t−γ
∫ t
0
xγdB(x)Σ
1/2
1 + (γ + 1)t
−γ
∫ t
0
xγ−1W (x)dxI−1/2(θ)
∂ρ(θ)
∂θ
.
By deriving the variability of the Gaussian process, we conclude the asymptotic normality.
Theorem 4.1 Suppose the distributions f1(·|θ1), . . . , fK(·|θK) of the outcomes of treatment
k = 1, . . . ,K follow an exponential family. Let g(x,y) be defined as (4.1). Then
√
n(θ̂n − θ) D→ N
(
0, I−1(θ)
)
,
Nn − nρ = O(
√
n log log n) a.s. and
√
n
(Nn
n
− ρ
)
D→ N
(
0,Σγ
)
,
where
Σγ = ΣLB +
1
1 + 2γ
(
diag(ρ) − ρ′ρ+ΣLB
)
with ΣLB being defined as in (3.8).
We can also derive the asymptotic joint normality of θ̂n and
Nn
n , the asymptotic co-variance
of them is Cov
{
θ̂n,
Nn
n
} ∼ 1nI(θ)∂ρ(θ)∂θ .
The asymptotic variability Σγ achieves its largest value when γ = 0, and approaches its
minimum value ΣLB as γ →∞.
In the case of two-treatment trials with binary responses, the RPW rule, the DL rule,
the SEU procedure with Dm = 1
′ρ(p̂m,1, p̂m,2), the GDL rule, the SMLP and the DBCD
can all applied to target the allocation q2/(q1 + q2). The asymptotic variabilities of the
sample allocation proportions Nn,1/n (after normalized by
√
n) are given in Table 1. It can
be verified that the RPW rule always has the largest variability and the DL rule has the
smallest variability. In fact,
σ2RPW > σ
2
SEU > σ
2
SMLP >
σ2GDL
σ2DBCD
> σ2DL,
for all 0 < q1, q2 < 1.
The RPW rule and DL rule can only target the allocation q2/(q1+ q2). The SEU design
with Dm = 1
′ρ(θ̂m), the GDL, the SMLP and the DBCD can be used to target any desired
allocation. Table 2 gives their asymptotic variabilities.
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Design RPW DL SMLP
Variability (σ2)
q1q2[3+2(p1+p2)]
[2(q1+q2)−1](q1+q2)2 , qq + q2 >
1
2 ,
∞, q1 + q2 ≤ 12
q1q2(p1+p2)
(q1+q2)3
q1q2(2+p1+p2)
(q1+q2)3
Design SEU GDL DBCD
Variability (σ2) q1q2[2+5(p1+p2)](q1+q2)3
2q1q2(p1+p2)
(q1+q2)3
q1q2[2+(1+2γ)(p1+p2)]
(1+2γ)(q1+q2)3
Table 1: The asymptotic variabilities of RAR procedures with the same traget q2q1+q2 .
Design SEU GDL SMLP DBCD
Variability (Σ) Σ1 + 6ΣLB 2ΣLB Σ1 + 2ΣLB
1
1+2γΣ1 +
2+2γ
1+2γΣLB
Table 2: The asymptotic variabilities of RAR procedures with the same traget ρ(θ).
4.3 Variability and Efficiency
For assessing theoretical operating characteristics of candidate designs, the first step is
assessing the theoretical (limit) allocation proportions under certain criteria, which is the
optimization problem as we discuss in subsection 4.1. The allocation proportion of the RPW
rule is not optimal under usual criteria. For given a desired allocation ρ(θ), the asymptotic
variability of the sample allocation proportions Nn/n is perhaps the most important issue.
The variability of sample allocation proportions can have a strong effect on power. This has
been demonstrated by many simulation studies of Melfi and Page (1998) and Rosenberger
et al. (2001), and theoretically by Hu and Rosenberger (2003), who show explicitly the
relationship between the power of a test and the variability of the randomization proce-
dure for a given allocation proportion. In the latter paper, the authors showed that the
average power of a randomization procedure is a decreasing function of the variability of
the procedure. Hu, Rosenberger and Zhang (2006) introduced asymptotically best response
adaptive randomization procedures as ones that have the smallest variance of the alloca-
tion proportion among the procedures targeting the same allocation. These results allow a
formal assessment of operating characteristics of various response-adaptive randomization
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designs. The following theorem of Hu, Rosenberger and Zhang (2006) shows that for any
given an allocation proportion, there is a lower bound of the asymptotic variability of the
sample allocation proportions which converge to this given allocation proportion.
Theorem 4.2 Assume the following regularity conditions:
1. The parameter space Θ of θ is an open set;
2. The distributions of responses f1(·|θ1), . . . , fK(·|θ1) follow an exponential family;
3. For the limiting allocation proportion ρ(θ) =
(
ρ1(θ), . . . , ρK(θ)
)
,
Nn,k
n
→ ρk(θ) a.s. k = 1, . . . ,K;
4. For a positive definite matrix V (θ),
√
n
(Nn
n
− ρ(θ)
)
D→ N(0,V (θ)).
Then there exists a Θ0 ⊂ Θ with Lebesgue measure 0 such that for every θ ∈ Θ \Θ0,
V (θ) ≥ ΣLB ,
where ΣLB is defined by (3.8).
We refer to an adaptive design that attains the lower bound as asymptotic best (or efficient)
for that particular allocation ρ(θ). Table 3 gives the lower bounds of the asymptotic vari-
abilities σ2LB for the urn proportion
q2
q1+q2
, the RSIHR proportion
√
p1√
p1+
√
p2
and the Neyman
proportion
√
p1q1√
p1q1+
√
p2q2
in a two-treatment clinical trial with binary responses.
ρ1(θ) σ
2
LB
Urn proportion q2q1+q2
q1q2(p1+p2)
(q1+q2)3
RSIHR proportion
√
p1√
p1+
√
p2
1
4(
√
p1+
√
p2)3
(
p2q1√
p1
+ p1q2√p2
)
Neyman proportion
√
p1q1√
p1q1+
√
p2q2
1
4(
√
p1q1+
√
p2q2)3
(
p2q2(1−2p1)2√
p1q1
+ p1q1(1−2p2)
2
√
p2q2
)
Table 3: Lower bounds of RAR procedures for several allocation proportions.
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For the case of two-treatment trials with binary responses, among the randomization
procedures as given in the last subsection which target the same allocation q2/(q1+ q2), the
RPW rule has the largest variability which is faraway from the lower bound, and the DL
rule is an asymptotically best response adaptive randomization procedure. For a general
allocation proportion ρ(θ), only the DBCD can approach an asymptotically best response
adaptive randomization procedure as γ →∞ (Table 2).
4.4 Efficient RAR Designs
Hu, Zhang and He (2009) proposed a class of efficient response adaptive randomization
designs, which are fully randomized, can target any allocation (under mild regularity con-
ditions), and are asymptotically best. The ERADE was proposed for comparing two treat-
ments. After m assignments, we let θ̂m = (θ̂m,1, θ̂m,2) be the MLE of the parameter
θ = (θ1,θ2). The probability of assigning the (m + 1)-th patient to treatment 1 is de-
fined by
pm+1,1 =

αρ1
(
θ̂m
)
, if Nmm > ρ1
(
θ̂m
)
,
ρ1
(
θ̂m
)
, if Nmm = ρ1
(
θ̂m
)
,
1− α(1− ρ1(θ̂m)), if Nmm < ρ1(θ̂m),
(4.2)
where 0 ≤ α < 1 is a pre-specified constant. When ρ(θ) ≡ 1/2, the procedure reduces
to the famous Efron’s biased coin design (Efron (1971)). The constant α is related to the
randomness of the design. When α = 1, the procedure reduces to the SMLP. When α is
smaller, the ERADE is more deterministic and could have smaller variability. Hu, Zhang
and He (2009) recommend choosing α between 0.4 and 0.7.
Theorem 4.3 Suppose the distributions f1(·|θ1) and f2(·|θ2) of the responses follow an
exponential family. Then
Nn,1 − nρ1 = O(
√
n log log n) a.s. and
max
m≤n
∣∣∣Nm,1 −mρ1(θ̂m)∣∣∣ = o(√n) in probability,
where ρ1 = ρ1(θ). In particular,
√
n
(
θ̂n − θ, Nn,1
n
− ρ1
)
D→ N (0,Λ) with
Λ =
 I−1(θ) I−1(θ)∂ρ1(θ)∂θ(∂ρ1(θ)
∂θ
)′
I−1(θ) σ2LB
 , σ2LB = (∂ρ1(θ)∂θ )′I−1(θ)∂ρ1(θ)∂θ .
Under the situation where efficiency is critically important, in theory, the ERADE should
be the best choice in all the response-adaptive randomization procedures. The simulation
evidence that the ERADE outperforms other procedures in most cases can be found in Hu,
Zhang and He (2009), Flournoy, Haines and Rosenberger (2014) etc. When the responses
are binary and the desired proportion is q2/(q1+q2), the DL rule is also an efficient response-
adaptive randomization procedure. However, simulations shows that the DL rule produces
an allocation that is suboptimal with respect to power. Its finite-sample variances are much
smaller than the corresponding asymptotic variances, but when p1 and p2 are large and
different, the DL rule does not converge to the target allocation proportion as fast as other
procedures (c.f. Hu, Zhang and Hu (2009)). Similar simulation evidence is also found for
the ERADE under some situations when the sample size is small. It sometimes does not
converge to the target allocation proportion as fast as the DBCD does, though its finite-
sample variances are always small. The main reason for such a phenomenon is possibly that
the allocation probabilities in the DL rule and the the ERADE are not stable, they always
jump from one value to another. A continuous allocation function can make the allocation
probabilities stable and speed up the convergence of the sample allocation proportions.
Very recently, Zhang et al. (2014b) proposed a new ERADE for multi-treatment trials
by defining a continuous allocation function. Let ψ(x) be a weight function given by
ψ(x) = 1 +
√(
x2γ − 1) ∨ 0, x ≥ 0.
Define the allocation function g(x,y) =
(
g1(x,y), . . . , gK(x,y)
)
by
gk(x,y) =
ykψ
( yk
xk
)∑K
j=1 yjψ
( yj
xj
) , k = 1, . . . ,K. (4.3)
After m assignments, the probability of assigning the (m + 1)-th patient to treatment k is
defined by
pm+1,k = gk
(
Nm
m
, ρ̂m
)
with ρ̂m = ρ(θ̂m), k = 1, . . . ,K.
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Theorem 4.4 Suppose the distributions f1(·|θ1), . . . , fK(·|θK) of the responses follow an
exponential family. Then pm+1,k → ρk, k = 1, . . . ,K,
Nn − nρ = O(
√
n log log n) a.s. and
max
m≤n
∥∥∥Nm −mρ(θ̂m)∥∥∥ = o(√n) in probability,
where ρ = (ρ1, . . . , ρK) = ρ(θ). Further there is a multi-dimensional standard Brownian
motion W (t) such that
n(θ̂n − θ) =W (n)I−1/2(θ) + o(
√
n) a.s. and
max
m≤n
∥∥∥∥Nm −mρ−W (m)I−1/2(θ)∂ρ(θ)∂θ
∥∥∥∥ = o(√n) in probability.
In particular,
√
n
(
θ̂n − θ,Nn
n
− ρ
)
D→ N (0,Λ) with
Λ =
 I−1(θ) I−1(θ)∂ρ(θ)∂θ(∂ρ(θ)
∂θ
)′
I(θ) ΣLB
 , ΣLB = (∂ρ(θ)
∂θ
)′
I−1(θ)
∂ρ(θ)
∂θ
.
5 Selection Bias and Lack of Randomness
If the experimenter can predict the next assignment, he may consciously or unconsciously
bias the experiment as to what treatment particular types of subjects should receive. Ran-
domization is used for neutralizing such bias in clinical trials. A natural measure of the
selection bias of a sequential design is the expected percentage of correct guesses the ex-
perimenter can make if he guesses optimally (c.f., Efron (1971)). Let Jm = 1 if the mth
assignment is guessed correctly, and Jm = 0 otherwise. The expected proportion of correct
guesses is the expected value of 1n
∑n
m=1 Jm. So selection bias of the design is defined by
SBn = E
[
1
n
n∑
m=1
Jm
]
=
1
n
n∑
m=1
P(Jm = 1).
It is obvious that, for a complete randomization, in which each patient is assigned to each
one of the K treatments with the same probability 1/K, the selection bias is SBn = 1/K
which is the smallest value of the selection biases of all randomization procedure in a trail
with K treatments. The selection bias can be regarded as a measure of lack of randomness.
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In a response-adaptive randomization procedure, the optimal guessing strategy is to
guess treatment k for which pm+1,k = maxj pm+1,j . So
P (Jm+1 = 1) = E[max
k
pm+1,k].
It is obvious that 1K ≤ SBn ≤ 1. When the allocation is not balance, the optimal value
1/K can not be attained. Zhang et al. (2014b) gives the minimum value of the asymptotic
selection bias.
Theorem 5.1 For any adaptive design, if Nn/n→ ρ(Θ) in probability, then
lim inf
n→∞ SBn ≥ maxk ρk(Θ).
Further, if pm+1,k → ρk(θ) in probability, k = 1, . . . ,K, then
SB =: lim
n→∞SBn = maxk
ρk(Θ).
According to this theorem, maxk ρk(Θ) is the minimum value of the asymptotic selection
bias with a target allocation proportion ρ(Θ). And, if the allocation probabilities converge
to the target allocation proportion, then the design attains the lower bound of the selection
bias. As a conclusion, the GPU, the SEU, the DBCD, the SMLP (as a special case of DBCD)
and the new ERADE of Zhang et al. (2014b) attains the lower bound of the selection bias.
However, the asymptotic selection bias SB of the Hu, Zhang and He (2009) procedure is a
monotone function of the parameter α, which coincides the intuition via the definition of
the allocation function.
Theorem 5.2 Consider the procedure of Hu, Zhang and He (2009) for two-treatment clin-
ical trials. Suppose that P(ρ1(Θ̂m) = v) = 0 for any rational v ∈ [0, 1]. Then we have
SB =
 1− 2αρ1ρ2, if ρ1 ∨ ρ2 ≤
1
2α ,
ρ1 ∨ ρ2, if ρ1 ∨ ρ2 ≥ 12α .
It turns out that only the new ERADE of Zhang et al. (2014b) achieves both the lower
bound of asymptotic variability and the lower bound of the selection bias.
Recall that for a sequence Y1, Y2, . . . , Yn of random variables taking values 0 and 1 with
mean p, they are completely random if and only if E[Yi|Fi−1] = p, i = 1, . . . , n. So
1
n
n∑
i=1
E
∣∣E[Yi|Fi−1]− p∣∣,
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can be regarded as a measure of the lack of randomness of this sequence. Therefore, for a
response-adaptive randomization procedure, we can define another measure of the lack of
randomness by
MLRn =
1
n
n∑
m=1
1
K
K∑
k=1
E
∣∣pm,k − ρk|.
It is obvious that if pm,k → ρk in probability, k = 1, . . . ,K, then
MLR =: lim
n→∞MLRn = 0.
So, for the GPU, the SEU, the DBCD and the new ERADE of Zhang et al. (2014b),
MLR = 0. For the procedure of Hu, Zhang and He (2009), MLR = 2(1 − α)ρ1ρ2 is a also
a decreasing function of α. The conclusion coincides with that for SB.
For further considering the degree of the lack of randomness of the designs withMLR =
0, we take the case of K = 2 as example. Recall that in the RPW rule,
pm+1,1 =
Ym,1
m
D∼ N(ρ1, σ˜2RPW
m
)
, σ˜2RPW =
q1q2
(2(q1 + q2)− 1)(q1 + q2)2 ,
when q1 + q2 > 1/2, and σ˜
2
RPW =∞ when q1 + q2 ≤ 1/2. So,
lim
n→∞
√
n(MLRn) = lim
n→∞
1√
n
n∑
m=1
√
2/πσ˜RPW
m1/2
=
√
8/π σ˜RPW ,
when q1 + q2 > 1/2, and limn→∞
√
n(MLRn) = ∞ when q1 + q2 ≤ 1/2. Similarly, for the
DBCD,
lim
n→∞
√
n(MLRn) =
√
8/π σ˜DBCD, σ˜
2
DBCD =
γ2ρ1ρ2 + (1 + γ)
2σ2LB
1 + 2γ
.
Because σ˜2DBCD is an increasing function of γ, the large is γ, the more is the lack of ran-
domness of the design. When γ = 0, the procedure is the most random one in the family
of DBCDs and limn→∞
√
n(MLRn) takes the smallest value
√
8/πσLB. This coincides the
intuition via the definition of the allocation function. It is easily to show that in the binary
response case with target allocation q2/(q1 + q2), σ˜RPW is also greater than σ
2
LB . We con-
jecture that in the class of all adaptive randomization procedures with a same allocation
target, the DBCD with γ = 0 (i.e. the SMLP) is the most random one. When γ = 0, the
allocation probability is ρ1(θ̂m) which is an asymptotically best estimator of ρ1(θ), and so
the adaptive randomization procedure is locally efficient.
For the new ERADE of Zhang et al. (2014b), we have limn→∞
√
n(MLRn) =∞.
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Hence, the efficiency and the randomness are always two conflicting features of adaptive
randomization designs. However, it is surprising that the variability of the RPW rule is
much higher than other designs including the DBCD, and at the same time, the RPW rule
is much less random than the DBCD when p1 + p2 is close to or exceeds 1.5. The value of
SB and MLR for the DL rule, the GDL rule and the IMU design is an open problem. It is
very possibly a positive constant depending the initial value of the urn composition.
6 Survival and Delayed Responses
In the framework of response-adaptive randomization designs discussed above, the outcomes
of the treatments are assumed to be complete and available immediately. In practices, many
clinical trials have time-to-event outcomes and the outcomes may be censored. The problem
of handling survival responses in response-adaptive randomization designs have been studied
by Rosenberger and Seshaiyer (1997), Zhang and Rosenberger (2007), Sverdlov Ryeznik
and Wong (2014) etc. For applying the response-adaptive randomization methodology to
survival trials, the first problem is how to derive the desired allocation under reasonable
optimization criteria. Several meaningful optimization methods have been proposed by
Zhang and Rosenberger (2007) and Sverdlov Ryeznik and Wong (2014) in the framework
of parameter survival models. The other problem is that, when the outcomes are time-to-
event, they are usually delayed and will not be observed before the next step of the sequential
procedure is carried out. The delay time is usually the observed time or the censoring time.
The estimation of the parameters and the updatie of the urn composition (when using urn
models), can only be processed according to observed responses. The effect of the delay of
treatment results is fist studied in theory by Bai, Hu and Rosenberger (2002) for the urn
compositions in GPU designs. After that, Hu and Zhang (2004b), Zhang et al. (2007), Sun,
Cheung and Zhang (2007) and Hu et al. (2008) has showed that the delay machine does
not effect the asymptotic properties of the sample allocation proportions for many adaptive
designs if the delay degree decays with a power rate. The basic reason is that the total
delayed responses is a high order infinitesimal of square root of the sample size when the
delay degree decays with a power rate.
To describe the delay machine, we let tm be the entry time of the m-th patient, where
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tm is an increasing sequence of random variables. Assume that {tm+1 − tm} is a sequence
of independent random variables. The response time of the m-th patient on treatment k is
denoted by rm(k). Suppose {rm(k);m ≥ 1} is a sequence of independent random variables,
k = 1, . . . ,K. Further, assume that {tm+1− tm, rm(k); k = 1, . . . ,K,m ≥ n} is independent
of the assignments X1, . . . ,Xn.
Assumption 6.1 Let δk(m, ℓ) = I{rm(k) ≥ tm+ℓ − tm} be an indicator function that takes
the value 1 if the outcome of the m-th patient on treatment k occurs after at least another ℓ
patients arrive at the trials, and 0 otherwise. Suppose for some constans C > 0 and β ≥ 2,
µk(m, ℓ) = P
(
δk(m, ℓ) = 1
) ≤ Cℓ−β, for all m, ℓ, k.
This assumption is widely satisfied. A practical approach is to assume that the entry
mechanism generates a Poisson process and the delay time has an exponential distribution
in which both {rm(k)} and {tm+1− tm} are sequences of i.i.d. exponential random variables
with means λk > 0 and λ0 > 0, respectively. This approach is common in clinical studies
and the probability µk(m, ℓ) is
(
λk/(λ0 + λk)
)ℓ
.
Let Sobsm,k (resp. N
obs
m,k) be the summation (resp. the number) of the outcomes on treat-
ment k observed prior to the (m+1)-th assignment, and Sm,k (resp. Nm,k) be the summation
(resp. the number) of all the outcomes of those being assigned to treatment k in the first
m patients, k = 1, . . . ,K. The total delayed responses are then Sm,k − Sobsm,k, k = 1, . . . ,K.
Then we have the following theorem.
Theorem 6.1 Suppose Assumption 6.1 is satisfied, and the responses on each treatment are
i.i.d. random variables having finite (2 + δ)-th moments. Then for some 0 < δ0 <
1
2 − 12+δ ,
we have
Sm,k − Sobsm,k = o(n1/2−δ0) a.s.
and Nm,k −Nobsm,k = o(n1/2−δ0) a.s.
7 Other RAR Designs and Concluding Remarks
Besides the response-adaptive randomization designs disused in this paper, many other
procedures have been proposed in literature. For example, Thompson (1933) described a
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Bayesian procedure to compute the probability that one treatment is better than another
with binary responses. Under a uniform prior distribution, the procedure yields the following
formula. Given sufficient statistics (Sm,1, Sm,2, Nm,1, Nm,2) after m patients, where Sm,1,
Sm,2 are the numbers of successes of treatment 1 and 2 respectively, then
P̂ (p1 > p2) =
∑Sm,1
a=0
(Sm,1+Sm,2−a
Sm,2
)(Nm,1−Sm,1+Nm,2−Sm,2
Nm,2−Sm,2
)( n+2
Nm,2+1
) .
Thall and Wathen (2007) reformulated this procedure by proposing the following response-
adaptive procedure:
pm+1,k =
[
P̂ (p1 > p2)
]c[
P̂ (p1 > p2)
]c
+
[
1− P̂ (p1 > p2)
]c .
They suggested selecting c = (Nm,1 +Nm,2)/(2n) and updating c adaptively to reduce the
root MSE of the procedure.
Various designs are usually proposed in different views. Note that a design is “good”
under one criterion may be not “good” under another criterion. A graphical comparison of
response-adaptive randomization procedures can be found in Flournoy, Haines and Roen-
berger (2014).
In this paper, we give an overview of important response-adaptive randomization designs
and their asymptotic theory. In practice, a successful application of a response-adaptive
randomization design in a clinical trial may depend on at least three essentials. The first
one is a good adaptive procedure. We suggest that the procedure should be fully randomized,
have small variabilities and converges fast to an allocation which is optimal under a given
optimization criterion. The main drawback of the RPW is that it has high variability. Also,
its allocation proportion is not an optimal allocation under opportune optimization criteria.
The second essential is a good estimation method to collect the information from the data
on time. The sufficient statics and MLE are usually suggested. When the sample size is
small, the Bayesian method is a reasonable candidate. Other estimators such as weighted
likelihood estimators, robust estimators can be also used. The third essential is a not-worse
start of the procedure. The performance of the RPW and urn models depend heavily on the
initial composition of the urn, especially when the sample size is not large. In a pediatric
trial of extracorporeal membrane oxygenation (ECMO; Bartlett et al., 1985), the RPW rule
with 2 initial balls, 1 of each type, was used to randomize the patients. After several initial
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assignments in which the balls added were all of the ECMO type, the urn composition
became very extreme so that the conventional therapy has very little chance to be selected.
If the RPW rule with 10 initial balls, 5 of each type, had been used, maybe the story would
have been different. The convergence of the urn proportions and the sample allocation
proportions for the RPW rule is very slow. The DBCD and the ERADE converge much
faster than the urn models. But also the initial estimator of the parameters may have some
effects on their operating characteristics, especially when the sample size is very small. A
relatively accurate initial estimator may improve the performance of the design. If there is
not enough information to get a good estimator at the initial several steps, the estimator or
the allocation probabilities are suggested to be modified such that the randomization is close
to the restricted randomization until a rwasonable quality estimator is available. For details
of the discuss about the applications of response-adaptive randomization designs, one can
refer to Rosenberger, Sverdlov and Hu (2012) and Sverdlov and Rosenberger (2013b).
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